EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Novel Phenazine 5,10-Dioxides Release • OH in Simulated Hypoxia and Induce Reduction of Tumour Volume In Vivo

María L Lavaggi, Mauricio Cabrera, Cristina Pintos, Carolina Arredondo, Gisela Pachón, Jorge Rodríguez, Stella Raymondo, José Pedro Pacheco, Marta Cascante, Claudio Olea-Azar, Adela López de Ceráin, Antonio Monge und 2 weitere

ISRN Pharmacology · 2011

DOI: 10.5402/2011/314209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ISRN Pharmacology, 2011. Verfasst von María L Lavaggi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Química Medicinal, Laboratorio de Química Orgánica, Facultad de Ciencias-Facultad de Química, Universidad de la República, 11400 Montevideo,…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Spanish Government, Red Temática de Investigación Cooperativa en Cáncer, Instituto de Salud Carlos III.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phenazine 5,10-dioxides (PDOs) are a new class of bioreductive cytotoxins, which could act towards tumours containing hypoxic regions. The PDOs selective-hypoxic bioreduction was probed in vitro ; however, the mechanism of action has not been completely explained. Besides, PDOs in vivo antitumour activities have not been demonstrated hitherto. We study the mechanism of hypoxic/normoxic cytotoxicity of PDO representative members. Electron spin resonance is used to confirm • OH production, alkaline comet assay to determine genotoxicity, and gel electrophoresis and flow cytometry to analyze DNA fragmentation and cell cycle distribution. Chemically induced rat breast tumours are employed to evaluate in vivo activities. For the most selective cytotoxin, 7(8)-bromo-2-hydroxyphenazine 5,10-dioxide (PDO1), exclusive hypoxic • OH production is evidenced, while for the unselective ones, • OH is produced in both conditions (normoxia and simulated hypoxia). In normoxia (Caco-2 cells), PDO1 induces cell-cycle arrest and DNA fragmentation but does not significantly induce apoptosis neither at IC 50 nor IC 80 . No difference in the comet-assay scores are observed in normoxia and simulated hypoxia being the unselective 2-amino-7(8)-bromophenazine 5,10-dioxide (PDO2) the most genotoxic. The in vivo efficacy with the absence of systemic toxicity of PDO1 and PDO2 is checked out. Results from this study highlight the potential of PDOs as new therapeutics for cancer.

Autor:innen und Institutionen

  • Grupo de Química Medicinal, Laboratorio de Química Orgánica, Facultad de Ciencias-Facultad de Química, Universidad de la República, 11400 Montevideo, Uruguay.

Förderung

  • Spanish Government
  • Red Temática de Investigación Cooperativa en Cáncer
  • Instituto de Salud Carlos III

Zitieren

APA

Lavaggi, M. L., Cabrera, M., Pintos, C., Arredondo, C., Pachón, G., Rodríguez, J., Raymondo, S., Pacheco, J. P., Cascante, M., Olea-Azar, C., López de Ceráin, A., Monge, A., Cerecetto, H., & González, M. (2011). Novel Phenazine 5,10-Dioxides Release • OH in Simulated Hypoxia and Induce Reduction of Tumour Volume In Vivo. ISRN Pharmacology. https://doi.org/10.5402/2011/314209

Vancouver

Lavaggi ML, Cabrera M, Pintos C, Arredondo C, Pachón G, Rodríguez J, et al. Novel Phenazine 5,10-Dioxides Release • OH in Simulated Hypoxia and Induce Reduction of Tumour Volume In Vivo. ISRN Pharmacology. 2011. doi:10.5402/2011/314209

BibTeX
@article{Lavaggi2011,
  author = {Lavaggi, María L and Cabrera, Mauricio and Pintos, Cristina and Arredondo, Carolina and Pachón, Gisela and Rodríguez, Jorge and Raymondo, Stella and Pacheco, José Pedro and Cascante, Marta and Olea-Azar, Claudio and López de Ceráin, Adela and Monge, Antonio and Cerecetto, Hugo and González, Mercedes},
  title = {Novel Phenazine 5,10-Dioxides Release • OH in Simulated Hypoxia and Induce Reduction of Tumour Volume In Vivo},
  journal = {ISRN Pharmacology},
  year = {2011},
  doi = {10.5402/2011/314209}
}
Kostenlos starten →